This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1093/SCHBUL/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q94318344
rdf:type
wikibase:Item
schema:description
наукова стаття article scientifique publié en 2019 wetenschappelijk artikel article by Gjessing Jensen Karsten et al published 9 April 2019 in Schizophrenia Bulletin
p:P577
wds:Q94318344-7436E63E-9910-4723-AA8A-55F4D3AFAE2D
wdt:P577
2019-04-09T00:00:00Z
p:P2093
wds:Q94318344-F655F2EC-C043-410C-A135-E4B9425E5718 wds:Q94318344-70E755F3-18A9-4BD9-A8AE-53EAC1B0C66C wds:Q94318344-72665696-50E6-4D9B-B1FA-C424903D3522 wds:Q94318344-CD0BCDF3-57F2-4A2F-8DD2-AFB6E36E2B8C wds:Q94318344-E2D2DB53-F232-4C40-ADB2-5307126457D5 wds:Q94318344-D19F9602-E14D-47CF-9D49-646C57FF4B21 wds:Q94318344-E283422E-F80A-40F1-9E77-698E45EA833B
wdt:P2093
Marie Stentebjerg Decara Dea Gowers Klauber Gjessing Jensen Karsten Jens Richardt Møllegaard Jepsen Frank Eriksson Anders Fink-Jensen Ditte Rudaa
rdfs:label
O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL
skos:prefLabel
O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL
schema:name
O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL
p:P50
wds:Q94318344-FB29E017-E73E-41E7-A0F4-0AC1BDF7591D wds:Q94318344-AF4A043D-CFC4-4221-B3EB-E8F1C49C9525 wds:Q94318344-5E8BDA2E-8CFC-408B-B84B-E575ECF604D1
wdt:P50
wd:Q56954221 wd:Q40274772 wd:Q90195048
p:P1476
wds:Q94318344-474A53BA-16D6-4BDC-9D52-252DE52DEF01
wdt:P1476
O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL
p:P304
wds:Q94318344-A93DA36F-B220-4620-B014-7F06842C853F
wdt:P304
S197-S197
p:P31
wds:Q94318344-85C8EAF0-2826-45B9-A8C0-628211565625
wdt:P31
wd:Q13442814
p:P921
wds:Q94318344-8C0826D9-4D52-45E6-A8F2-FC6F2F57F324 wds:Q94318344-190B5851-4C96-411C-A1C9-309C408DC2BB
wdt:P921
wd:Q170082 wd:Q41112
p:P1433
wds:Q94318344-EB66BF33-F8DF-4567-9CAC-29CA78B0C8A8
wdt:P1433
wd:Q4049133
p:P433
wds:Q94318344-F9BA01C3-CA71-44B4-80DC-C44B15E78D75
p:P478
wds:Q94318344-33AD4BBE-6BDD-40F5-86A0-9189DF937F41
wdt:P433
Suppl 2
wdt:P478
45
p:P356
wds:Q94318344-EA3BA1C1-C22C-4776-AC42-C4DD68CF344E
wdtn:P356
n11:SBZ021.265
wdt:P356
10.1093/SCHBUL/SBZ021.265
p:P932
wds:Q94318344-C6C61BD3-9311-40D9-96B8-83C98A87CCA9
wdt:P932
6455381